Anti-MAM antibodies in rheumatic disease: Evidence for a MAM-like superantigen in rheumatoid arthritis?

Journal of Rheumatology

Volumn 27, Issue 2, 2000, Pages 358-364

  Sawitzke, Allen ^a   Joyner, David ^b   Knudtson, Kevin ^b   Mu, Hong Hua ^b   Cole, Barry ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Autoimmune Disease; Rheumatoid Arthritis; Spondylitis; Superantigens; Systemic Lupus Erythematosus

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN MU CHAIN; MITOGENIC AGENT; RHEUMATOID FACTOR; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ANKYLOSING SPONDYLITIS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MYCOPLASMA ARTHRITIDIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REITER SYNDROME; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANTIBODIES; ANTIGENS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MITOGENS; PROTEINS; SUPERANTIGENS;

EID: 0033965823     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Marrack P, Blackman M, Kushnir E, Kuppler J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med 1990;171:455-64.
2. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 1989;86:8941-5.
3. Acha-Orbea H, Palmer E. Mls - a retrovirus exploits the immune system. Immunol Today 1991;12:356-61.
4. Cole BC, Kartchner DR, Wells DJ. Stimulation of mouse lymphocytes by it mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct Vβ T cell receptors from various strains of mice by the "superantigen" MAM. J Immunol 1990;144:425-31.
5. Rose NR, Mackay IR. Autoimmunity horizons. In: Rose NR, Mackay IR, editors. The autoimmune diseases. II. 1st ed., vol. 1. San Diego: Academic Press; 1992:1-23.
6. Posnett DN. Do superantigens play a role in autoimmunity? Semin Immunol 1993;5:65-72.
7. Kotzin BL, Leung DY, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol 1993;54:99-166.
8. Cole BC, Griffiths MM. Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM. Arthritis Rheum 1993;36:994-1002.
9. Sawitzke AD, Knudtson KL, Cole BC. Bacterial superantigens in disease. In: Roth JA, Bolin CA. Brogden KA, Minion FC, Wannemuehler MJ, editors. Virulence mechanisms of bacterial pathogens. 2nd ed. Washington. DC: American Society for Microbiology: 1995;145-69.
10. Sayama K, Midorikawa K, Hanakawa Y, Sugai M, Hashimoto K. Superantigen production by Staphylococcus aureus in psoriasis. Dermatology 1998;196:194-8.
11. Zagon G, Tumang JR, Li Y, Riedman SM, Crow MK. Increased frequency of Vβ17-positive T cells in patients with rheumatoid arthritis. Arthritis Rheum 1994;37:1431-40.
12. Conrad B, Weidmann E, Trucco G, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature (London) 1994;371:351-5.
13. Lewis HM, Baker BS, Bokth S. et al. Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br J Dermatol 1993;129:514-20.
14. Abe J, Kotzin BL, Jujo K, et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci USA 1992;89:4066-70.
15. Luppi P, Rudert WA, Zanone MM, et al. Idiopathic dilated cardiomyopathy: a superantigen-driven autoimmune disease. Circulation 1998;98:777-85.
16. Cole B, Sawitzke A. Mycoplasmas, superantigens and autoimmune arthritis. In: Henderson J. Edwards J, Pettipher E, editors. Mechanisms and models in rheumatoid arthritis. London: Academic Press; 1995;47-66.
17. Howell MD, Diveley JP, Lurideen KA, et al. Limited T-cell receptor β-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Natl Acad Sci USA 1991;88:10921-5.
18. Paliard X, West SG, Lafferty JA, et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991;253:325-9.
19. Li Y, Sun GR, Tumang JR, Crow MK, Friedman SM. CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells. Evidence for an antigen-driven response. J Clin Invest 1994;94:2525-31.
20. Hodtsev AS, Choi Y, Spanopoulou E, Posnett DN. Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor. J Exp Med 1998;187:319-27.
21. Brocke S, Gaur A, Piercy C, et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature (London) 1993;365:642-4.
22. Burns J, Littlefield K, Gill J, Trotter J. Bacterial toxin superantigens activate human T lymphocytes reactive with myelin autoantigens. Ann Neurol 1992;32:352-7.
23. Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993;167:997-1002.
24. Khan M, van der Linden S. A wider spectrum of spondyloarthropathies. Semin Arthritis Rheum 1990;20:107-13.
25. Aly R, Maibech HI, Mandel A. Bacterial flora in psoriasis. Br J Dermatol 1976;95:603-6.
26. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24
27. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
28. Clegg DO, Reda DJ, Weisman MH, et al. Comparison of sultasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). Arthritis Rheum 1996;39:2021-7.
29. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current protocols in immunology, vol. 1. New York: Greene Publishing Associates and Wiley-Intersciene: 1991.
30. Knudtson KL, Manohar M, Joyner DE, Ahmed EA, Cole BC. Expression of the superantigen Mycoplasma arthritdis mitogen in Escherichia coli and characterization of the recombinant protein Infect Immun 1997;65:4965-71.
31. Emery P, Panayi GS, Welsh KI, Cole BD. Rheumatoid factors and HLA-DR4 in RA. J Rheumatol 1985;12:217-22
32. Cole BC, Atkin CL. Identification, characterization and purification of mycoplasmal superantigens. In Razin S, Tully JG, editors. Molecular and diagnostic procedures in mycoplasmalogy. vol. 1. New York: Academic Press; 1995:439-19.
33. Harris ED. Etiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology, vol 1. Philadelphia: W.B. Saunders: 1993;833-74.
34. Lim KK, Sharif M. Interference by IgM rheumatoid factor on ELISA for antibodies to mycobacterial 65 kDa heat shock protein in rheumatoid arthritis [letter; comment]. Br J Rheumatol 1996;35:300-1
35. Martins TB, Jaskowski TD, Mouritsen CL, Hill HR. An evaluation of the effectiveness of three immunoglobulin G (IgG) removal procedures for routine IgM serological testing Clin Diagn Lab Immunol 1995;2:98-103.
36. Takei S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993;91:602-7.
37. Origuchi T, Eguchi K, Kawabe Y, et al. Increased levels of serum IgM antibody to staphylococcal enterotoxin B in patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:713-20.
38. Cole BC, Washburn LR, Taylor-Robinson D. Mycoplasma induced arthritis. In: Razin S, Barile MF, editors. The mycoplasmas. vol. 4. New York: Academic; 1985:107-60.
39. Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BAC. Minocycline in active rheumatoid arthritis: a double-blind, placebo controlled trial. Arthritis Rheum 1994;37:629-36.
40. Tilley BC, Alarcon GS, Heyse SP, et al. Minocycline in rheumatoid arthritis. A 48-week double-blind, placebo-controlled trial. MIRA Trial Group [see comments]. Ann Intern Med 1995;122:81-9.
41. Johnson HM, Russell JK, Pontzer CH. Staphylococcal enterotoxin superantigens. Proc Soc Exp Biol Med 1991;198:765-71.
42. Cole BC, Knudtson KL, Oliphant A, et al. The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains with microbial superantigens and plant lectins J Exp Med 1996;183:1105-10.
43. Knudsin R, Praznik J. Pharyngeal carriage of mycoplasma species in healthy young adults. J Immunol 1967;86:579-83.
44. Taylor Robinson D, Schaeverbcke T. Mycoplasmas in rheumatoid arthritis and other human arthritides [editorial]. J Clin Pathol 1996;49:781-2.
45. Biberfield G. Infection sequelae and autoimmune reactions in Mycoplasma infection. In: Razin S, Barile M, editors The mycoplasmas. Orlando: Academic Press; 1985:293-311.
46. Schaeverbeke T, Renaudin H, Clerc M, et al. Systematic detection of mycoplasmas by culture and polymerase chain reaction procedures in 209 synovial fluid samples. Br J Rheumatol 1997;36:310-4.
47. Taylor Robinson D, Gilroy CB, Horowitz S, Horowitz J. Mycoplasma genitalium in the joints of two patients with arthritis. Eur J Clin Microbiol Infect Dis 1994;13:1066-9.
48. Puechal X, Roulland Dussoix D, Menkes CJ. Rheumatoid arthritis: failure to isolate or detect mycoplasmas [letter]. J Rheumatol 1997;24:1445-6.
49. Schaeverbeke T, Gilroy CB, Bebear C, Dehais J, Taylor Robinson D. Mycoplasma fementans in joints of patients with rheumatoid arthritis and other joint disorders [letter]. Lancet 1996;347:1418.
50. Schaeverbeke T, Gilroy CB, Bebear C, Dehais J, Taylor Robinson D. Mycoplasma fermentans, but not M penetrans, detected by PCR assays in synovium from patients with rheumatoid arthritis and other rheumatic disorders. J Clin Pathol 1996;49:824-8.
51. Dybvig K. Voelker LL. Molecular biology of mycoplasmas. Annu Rev Microbiol 1996;50:25-57.
52. Baccala R, Smith LR, Vestberg M, Peterson PA, Cole BC, Theofilopoulos AN. Mycoplasma arthritidis mitogen. Vβ engaged in mice, rats, and humans, and requirement of HLA-DRα for presentation. Arthritis Rheum 1992;35:434-42.
53. Friedman SM, Crow MK, Tumang JR, et al. Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against Vβ17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cells. J Exp Med 1991;174:891-900.
54. Posnett DN, Hodtsev AS, Kabak S, Friedman SM, Cole BC, Bhardwaj N. Interaction of mycoplasma arthritidis superantigen with human T cells. Clin Infect Dis 1993;17 Suppl 1:8170-5.
55. Hodtsev AS, Bhardwaj N, Posnett DN. TCR Jβ product influences superantigen reactivity [abstract]. J Cell Biochem Suppl 1994;18D:188A.
56. Howell MD, Diveley JP, Lundeen KA, et al. Limited T-cell receptor beta-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc Natl Acad Sci USA 1991;88:10921-5.